Correction to: Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active (Gene Therapy, (2022), 29, 12, (655-664), 10.1038/s41434-021-00235-z)

Luca Giordano, Manish K. Aneja, Natascha Sommer, Nasim Alebrahimdehkordi, Alireza Seraji, Norbert Weissmann, Carsten Rudolph, Christian Plank, Howard T. Jacobs, Marten Szibor

Research output: Contribution to journalComment/debate

Abstract

Correction to: Gene Therapyhttps://doi.org/10.1038/s41434-021-00235-z, published online 04 March 2021 We have become aware of an error in Supplementary Fig. 2 of this paper. Two loading controls for a western blot (ɑ-Tubulin and GAPDH) were immunolabeled on the same membrane and thus showed a similar expression pattern. Due to an unfortunate oversight, we cropped and presented ɑ-Tubulin twice. We here provide a corrected Supplementary Fig. 2b, replacing the erroneous panels with a new one from the original immunoblot, that now shows both ɑ-Tubulin (Cell Signaling, Cat. # 3873) and GAPDH (Cell Signaling, Cat. # 2118S) expression. Of note, the interpretation of the presented data is unchanged.

Original languageEnglish
Pages (from-to)528
Number of pages1
JournalGene Therapy
Volume31
Issue number9-10
DOIs
StatePublished - Sep 2024

Fingerprint

Dive into the research topics of 'Correction to: Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active (Gene Therapy, (2022), 29, 12, (655-664), 10.1038/s41434-021-00235-z)'. Together they form a unique fingerprint.

Cite this